| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |